Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

46,151

datasets available to search

ShareScore release 0.7.1

Reset

Dataset results

46,151 results for “Safety”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica

ClinicalTrials.gov study NCT03600818. IPD Sharing: YES. Countries: 17. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency

ClinicalTrials.gov study NCT02292654. IPD Sharing: YES. Countries: 6. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

ClinicalTrials.gov study NCT02787551. IPD Sharing: YES. Countries: 9. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression

ClinicalTrials.gov study NCT03756129. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

ClinicalTrials.gov study NCT02999633. IPD Sharing: YES. Countries: 7. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

ClinicalTrials.gov study NCT02819635. IPD Sharing: YES. Countries: 46. Publications: 13.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer

ClinicalTrials.gov study NCT02323126. IPD Sharing: YES. Countries: 8. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

ClinicalTrials.gov study NCT00649389. IPD Sharing: YES. Countries: 2. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patient

ClinicalTrials.gov study NCT03379727. IPD Sharing: YES. Countries: 15. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor

ClinicalTrials.gov study NCT04444895. IPD Sharing: YES. Countries: 10. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

ClinicalTrials.gov study NCT02477332. IPD Sharing: UNDECIDED. Countries: 10. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

ClinicalTrials.gov study NCT02268526. IPD Sharing: YES. Countries: 6. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis

ClinicalTrials.gov study NCT01989468. IPD Sharing: UNDECIDED. Countries: 13. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

ClinicalTrials.gov study NCT01896102. IPD Sharing: YES. Countries: 6. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

ClinicalTrials.gov study NCT03011372. IPD Sharing: YES. Countries: 11. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation

ClinicalTrials.gov study NCT03930732. IPD Sharing: YES. Countries: 24. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Tiny Cargo, Big Deal! An ED-Based Study of Child Passenger Safety Behaviors

ClinicalTrials.gov study NCT04238247. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

ClinicalTrials.gov study NCT01870726. IPD Sharing: UNDECIDED. Countries: 5. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

ClinicalTrials.gov study NCT04278417. IPD Sharing: YES. Countries: 16. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

ClinicalTrials.gov study NCT04739059. IPD Sharing: YES. Countries: 14. Publications: 0.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record